Patients with Systemic Sclerosis have higher healthcare utilization and Complication Rates after Total Hip Arthroplasty.
To assess whether outcomes after primary total hip arthroplasty (THA) differ in Systemic Sclerosis (SSc). We used the 1998-2014 U.S. National Inpatient Sample. THA and SSc were identified using procedure and diagnostic codes, respectively. Multivariable-adjusted logistic regression analyses assessed the association of SSc with in-hospital complications (implant infection, revision, transfusion, mortality) post-THA and associated healthcare utilization (hospital charges, hospital stay, discharge to non-home setting), adjusting for age, sex, race, Deyo-Charlson comorbidity index, primary diagnosis for THA, household income, and insurance payer.. Of the 4,116,485 primary THAs performed in the U.S. 1998-2014, 2,672 (0.06%) had SSc. In multivariable-adjusted analyses, compared to people without SSc, people with SSc had higher adjusted odds ratios [OR] (95% confidence interval [CI]) of the following post-primary THA: (1) non-home discharge, 1.25 (95% CI, 1.03, 1.50); (2) hospital stay >3 days, 1.61 (95% CI, 1.35, 1.92); (3) transfusion, 1.54 (95% CI, 1.28, 1.84); and (4) revision, 9.53 (95% CI, 6.75, 13.46). Differences in mortality had a nonsignificant trend, 2.19 (95% CI, 0.99, 4.86). There were no differences in total hospital charges or implant infection rates. SSc was associated with higher rate of in-hospital complications and healthcare utilization post-primary THA. Future studies should examine whether pre- or post-operative interventions can reduce the risk of post-THA complications in people with SSc.